Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea

Leukemia. 2021 Feb;35(2):623-627. doi: 10.1038/s41375-020-0849-2. Epub 2020 May 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Genomics / methods*
  • Humans
  • Hydroxyurea / pharmacology*
  • Polycythemia Vera / drug therapy
  • Polycythemia Vera / genetics*
  • Polycythemia Vera / pathology
  • Prognosis
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Hydroxyurea